16 January 2022 12:56 - Renata E
Collaboration between pharmaceutical companies and healthcare providers is essential for advancing GLP-1 therapies
In receptor subtype profiling, laboratories can compare behavior across defined receptor complex constructs or cell backgrounds that vary receptor activity modifying protein composition
Here's everything you need to know about it including why you can't get it yet, and what that means for your options right now
( Epub 2021 Aug 17 PMID: 34403495 ) Vallatharasu Y, Hayashi-Tanner Y, Polewski PJ, Bottner WA, Rosenstein LJ, Uprety D, Bista A, Farnen JP, Aster R (2019) Severe, prolonged thrombocytopenia in a patient sensitive to exenatide